The emerging treatment of this peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing medications, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide717309.mdkblog.com/48247602/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment